Pejchinovski Martin, Hrnjez Dajana, Ramirez-Torres Adela, Bitsika Vasiliki, Mermelekas George, Vlahou Antonia, Zürbig Petra, Mischak Harald, Metzger Jochen, Koeck Thomas
Mosaiques Diagnostics GmbH, Hanover, Germany.
Biotechnology Division, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Proteomics Clin Appl. 2015 Jun;9(5-6):453-68. doi: 10.1002/prca.201400113. Epub 2015 Apr 7.
Clinical proteomics, a rapidly growing field, intends to use specific diagnostic proteomic/peptidomic markers for initial diagnosis or prognosis of the progression of various diseases. Analyses of disease-associated markers in defined biological samples can provide valuable molecular diagnostic information for these diseases. This approach relies on sensitive and highly standardized modern analytical techniques. In the recent years, one of these technologies, CZE online coupled to MS (CZE-MS), has been increasingly used for the detection of peptide biomarkers (<20 kDa) in body fluids such as urine. This review presents the most relevant urinary proteomic studies addressing the application of CZE-MS in clinically relevant biomarker research between the years 2006 and 2014.
临床蛋白质组学是一个快速发展的领域,旨在使用特定的诊断蛋白质组学/肽组学标志物对各种疾病的进展进行初步诊断或预后评估。对特定生物样本中与疾病相关的标志物进行分析可为这些疾病提供有价值的分子诊断信息。这种方法依赖于灵敏且高度标准化的现代分析技术。近年来,其中一种技术,即毛细管区带电泳在线联用质谱(CZE-MS),越来越多地用于检测尿液等体液中的肽生物标志物(<20 kDa)。本综述介绍了2006年至2014年间关于CZE-MS在临床相关生物标志物研究中的应用的最相关尿液蛋白质组学研究。